Halcón Resources Announces Third Quarter 2018 Results and Provides an Operational Update
Record 30 and 60-Day IP Rates on Recent Monument Draw Wells DENVER, Nov. 07, 2018 (GLOBE NEWSWIRE) — Halcón Resources […]
Brookfield Infrastructure Renews Its Limited Partnership Unit and Preferred Unit Normal Course Issuer Bids
BROOKFIELD, NEWS, Nov. 07, 2018 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (“Brookfield Infrastructure”) (NYSE: BIP; TSX: BIP.UN) today announced […]
TransUnion Declares Third-Quarter 2018 Dividend of $0.075 per Share
CHICAGO, Nov. 07, 2018 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) today announced that its Board of Directors declared a cash […]
Genco Shipping & Trading Limited Announces Third Quarter Financial Results
Completed Acquisitions of Six High Specification, Fuel Efficient Capesize and Ultramax Vessels Entered into a $108 Million Credit Facility with […]
Profire Energy Reports Financial Results for Third Quarter Fiscal 2018
Profire Increased Net Income by 36% Over the Same Quarter in 2017 LINDON, Utah, Nov. 07, 2018 (GLOBE NEWSWIRE) — […]
Profire Energy Reports Financial Results for Third Quarter Fiscal 2018
Profire Increased Net Income by 36% Over the Same Quarter in 2017 LINDON, Utah, Nov. 07, 2018 (GLOBE NEWSWIRE) — […]
Geron to Present at Upcoming Investor Conferences in November
MENLO PARK, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., […]
Geron to Present at Upcoming Investor Conferences in November
MENLO PARK, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., […]
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
CRESTWOOD, Ky. and WALTHAM Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused […]
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
CRESTWOOD, Ky. and WALTHAM Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused […]
